Definitive Contract HHSD200201563359C
Award Date
6/26/15
Potential Completion Date
8/7/15
Potential Value
$208K
Federal Agency
CDC Office of Acquisition Services
Awardee
Fluoresentric, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park City, UT, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract to Fluoresentric, Inc., a for-profit manufacturer of goods, for $207,900.00. The contract is for unspecified "other functions" and does not have a set-aside designation. The place of performance is Atlanta, GA. The contract period of performance ends on September 30, 2017.</p>
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $203,805.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing supplies, for laboratory reagents and supplies. This purchase order, which has no set-aside designation, will be performed in Salt Lake City, Utah and supports the CDC's diagnostic testing capabilities. XCR Diagnostics, Inc. is a wholly owned subsidiary of Fluoresentric, Inc.,...
This federal contract award of $88,203.06 was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a division of Thermo Fisher Scientific, to provide laboratory supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type, and no set-aside designation. Life Technologies Corporation is the prime contractor, leveraging its expertise as a manufacturer of scientific instruments, reagents, and consumables to...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...
The Centers for Disease Control and Prevention (CDC) awarded a $19,502 purchase order to Illumina, Inc. for lab supplies under a firm fixed price contract. The CDC, a component of the Department of Health and Human Services, supports programs focused on public health and disease prevention. This award will provide Illumina the opportunity to deliver laboratory materials to assist the CDC in carrying out its important mission over the approximately two-month period of performance ending in late...